Vanishing white matter disease, a rare leukodystrophy with mutation in the EIF2B5 gene

被引:0
|
作者
Sinko, Gabriella [1 ]
Tompa, Marton [2 ,3 ]
Kiss, Zsuzsanna [4 ]
Kalman, Bernadette [2 ,5 ]
机构
[1] Markusovszky Univ, Dept Pediat, Teaching Hosp, Szombathely, Hungary
[2] Markusovszky Univ, Teaching Hosp, Ctr Mol Med, Szombathely, Hungary
[3] Szentagotha Res Ctr, Hungarian Ctr Genom & Bioinformat, Pecs, Hungary
[4] Markusovszky Univ, Dept Lab Med, Div Clin Genet, Teaching Hosp, Szombathely, Hungary
[5] Univ Pecs, Sch Med, Dept Lab Med, Pecs, Hungary
来源
关键词
vanishing white matter disease; whole exome sequencing; RATING-SCALE; HYPERINTENSITIES; MRI; DEMENTIA;
D O I
10.18071/isz.77.0207
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background - Leukodystrophies, a hete roge neous group of brain and spinal cord dis orders, often pose challenges in es tab li shing molecular etiology. Vanishing White Matter Disease (VWMD) is a rare sub type of leu kodys trophies presenting with characteristic clinical and MRI features, ne ver theless, achieving diag nostic certainty requires genetic studies. Case presentation - Our patient is a nine year old girl, who developed progressive gait difficulties at around 3-4 years of age. Her brain MRI showed confluent lesions with increased signal intensity in the cerebral and cerebellar white matter on T2/FLAIR se quen ces, within which hypointense regions ap peared with signal intensity resembling that of the cerebrospinal fluid on T1 sequences. Whole exome sequencing identified a homozygous likely pathogenic variant within the EIF2B5 gene in the proband, which was present in a heterozygous state in both asymptomatic parents. Having the clinical and molecular genetic diagnosis established, we explored therapeutic possibilities for the patient. Conclusion - VWMD is a severe form of leukodystrophies with little or no disease modifying therapy available until recently. A better understanding of its molecular pathogenesis offers some hope for new inventive therapies.
引用
收藏
页数:69
相关论文
共 50 条
  • [31] Characterisation of EIF2B bodies in vanishing white matter disease
    Hodgson, R.
    Allen, K. E.
    Campbell, S.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 219 - 220
  • [32] Vanishing white matter leukodystrophy, a rare case report
    Guler, Serhat
    Yuksel, Adnan
    Iscan, Akin
    Isik, Ilhan
    Tatli, Burak
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2013, 48 (01): : 78 - 79
  • [33] VANISHING WHITE MATTER DISEASE DUE TO VARIANT MUTATIONS IN THE EIF2B-1 GENE
    Priya, Bangalore
    Ian, Berry R.
    John, Livingston
    Dan, Warren
    David, Nicholl J.
    Mary, O'Driscoll
    Tom, Hayton
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [34] Association Between Late-Onset Leukoencephalopathy With Vanishing White Matter and Compound Heterozygous EIF2B5 Gene Mutations: A Case Report and Review of the Literature
    Kong, Fanxin
    Zheng, Haotao
    Liu, Xuan
    Lin, Songjun
    Wang, Jianjun
    Guo, Zhouke
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [35] Novel mutation in EIF2B gene in a case of adult-onset leukoencephalopathy with vanishing white matter
    Matsui, Masaru
    Mizutani, Kotaro
    Ohtake, Hiroaki
    Miki, Yukio
    Ishizu, Koichi
    Fukuyama, Hidenao
    Shimohata, Takayoshi
    Onodera, Osamu
    Nishizawa, Masatoyo
    Takayama, Yoshihiro
    Shibasaki, Hiroshi
    EUROPEAN NEUROLOGY, 2007, 57 (01) : 57 - 58
  • [36] A POINT MUTATION IN EIF2B5 LEADS TO DELAYED AND ABNORMAL DEVELOPMENT OF BRAIN WHITE MATTER IN A MOUSE MODEL FOR CACH/VWM
    Cabilly, Y.
    Geva, M.
    Assaf, Y.
    Mindroul, N.
    Elroy-Stein, O.
    GLIA, 2009, 57 (13) : S91 - S91
  • [37] Adult-Onset Vanishing White Matter Disease Due to a Novel EIF2B3 Mutation
    La Piana, Roberta
    Vanderver, Adeline
    van der Knaap, Marjo
    Roux, Louise
    Tampieri, Donatella
    Brais, Bernard
    Bernard, Genevieve
    ARCHIVES OF NEUROLOGY, 2012, 69 (06) : 765 - 768
  • [38] Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation.: First Polish cases
    Mierzewska, Hanna
    van der Knaap, Marjo S.
    Scheper, Gert C.
    Jurkiewicz, Elzbieta
    Schmidt-Sidor, Bogna
    Szymanska, Krystyna
    FOLIA NEUROPATHOLOGICA, 2006, 44 (02) : 144 - 148
  • [39] GENE EXPRESSION PROFILE IN THE BRAIN OF A MOUSE MODEL FOR CACH/VWM DISEASE DUE TO A POINT MUTATION IN EIF2B5
    Marom, L.
    Geva, M.
    Elroy-Stein, O.
    GLIA, 2009, 57 (13) : S48 - S49
  • [40] Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course
    Sambati, Luisa
    Agati, Raffaele
    Bacci, Antonella
    Bianchi, Silvia
    Capellari, Sabina
    NEUROLOGICAL SCIENCES, 2013, 34 (07) : 1235 - 1238